Article
Gene transfer of master autophagy regulator TFEB results in clearance of toxic protein and correction of hepatic disease in alpha-1-anti-trypsin deficiency.
EMBO molecular medicine - 1 Mar 2013
Pastore Nunzia, Blomenkamp Keith, Annunziata Fabio, Piccolo Pasquale, Mithbaokar Pratibha, Maria Sepe Rosa, Vetrini Francesco, Palmer Donna, Ng Philip, Polishchuk Elena, Iacobacci Simona, Polishchuk Roman, Teckman Jeffrey, Ballabio Andrea, Brunetti-Pierri Nicola
Abstract excerpt
Alpha-1-anti-trypsin deficiency is the most common genetic cause of liver disease in children and liver transplantation is currently the only available treatment. Enhancement of liver autophagy increases degradation of mutant, hepatotoxic alpha-1-anti-trypsin (ATZ). We investigated the therapeutic potential of liver-directed gene transfer of transcription factor EB (TFEB), a master gene that regulates lysosomal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
